AGEE NANCY H 4

What Happened
Nancy H. Agee, a director of Precigen, disclosed that 71,839 restricted stock units (RSUs) vested on March 13, 2026 and were converted into 71,839 shares of Precigen common stock. The Form 4 lists an acquisition of 71,839 shares via conversion (derivative code M) and a simultaneous disposition of 71,839 shares at $0.00. No cash value is reported in the filing for the disposition.

Key Details

• Transaction date: March 13, 2026; Form 4 filed March 16, 2026 (timely within SEC two-business-day window).
• Transaction codes: M (exercise/conversion of derivative) — Acquired 71,839 shares; Disposed 71,839 shares at $0.00.
• Footnotes: F1 — each RSU equals one share; F2 — the RSUs vested in full on March 13, 2026.
• Shares owned after the transactions are not specified in the provided excerpt.
• Filing does not include a specific tax-withholding code or cash amount for the disposition.

Context
This was a vesting/conversion of RSUs (an award becoming stock), not an open-market buy or sale by the insider. The simultaneous acquisition and $0.00 disposition in the filing may reflect a conversion/settlement mechanism, but the Form 4 and footnotes only confirm that the RSUs vested and converted; no further detail (e.g., tax withholding) is stated. Such vesting events are common and typically routine rather than an explicit market-timing signal.